p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer

Martina Gruber(Innsbruck Medical University), Zoran Čulig(Innsbruck Medical University)
Endocrine Related Cancer
January 28, 2020
Cited by 28


Related Papers